Therapeutic Area
Dermatology CDMOs
Compare CDMOs with dermatology drug manufacturing expertise for topical formulations, transdermal systems, and injectable biologics for skin conditions. Filter by dosage form, scale, and certifications.
106 companies listed
About Dermatology Drug Manufacturing
Dermatology drug manufacturing is dominated by topical formulations -- creams, ointments, gels, lotions, foams, and solutions. These semi-solid dosage forms require specialized mixing equipment (high-shear mixers, homogenizers), precise temperature control during formulation, and validated filling lines for tubes, jars, pumps, and airless dispensers. The manufacturing expertise is distinct from solid dose or injectable production.
Skin penetration is the formulation challenge. The stratum corneum (outermost skin layer) is an effective barrier that most drugs cannot cross easily. CDMOs need formulation scientists experienced with penetration enhancers, nano-emulsions, liposomal delivery, and permeation testing (Franz diffusion cells). The choice of vehicle (cream vs ointment vs gel) significantly affects drug delivery and patient acceptance.
Biologics are entering dermatology. Monoclonal antibodies for psoriasis (anti-IL-17, anti-IL-23), atopic dermatitis (anti-IL-4R, anti-IL-13), and other inflammatory skin conditions have transformed treatment. While these are manufactured as standard injectable biologics, the combination with topical products in treatment protocols means some CDMOs serve both modalities for dermatology sponsors.
Companies (106)
Tulip Lab Pvt Ltd
India
Tulip Lab Pvt Ltd is an Indian pharmaceutical manufacturing company headquartered in Mumbai. ISO 22000 certified and PIC/S certified, they manufacture allopathic and herbal products including tablets, capsules, liquids, and topicals. Their product range covers essential care, lifestyle diseases, cardiology, women's well-being, and metabolic disorders. They offer formulation development, private label, and contract manufacturing services with GMP-compliant facilities.
Small Molecule Drug ProductOral Solid DoseFormulation Development
UNI-PHARMA S.A.
Greece
UNI-PHARMA S.A. is a major Greek pharmaceutical company (part of the Tsetis Group) with over 60 years of operations. It researches, develops, produces, and distributes pharmaceutical products, food supplements, and medical devices. It holds the first place in sales (units) among purely Greek companies in the Greek pharmaceutical market. The company offers contract manufacturing services (listed as CMO/CDMO on PharmaSource) while also marketing its own extensive portfolio of generic medicines across multiple therapeutic categories. Their product range includes a very wide array of small-molecule generics.
Frequently Asked Questions
What formulation capabilities are needed for topical drug manufacturing?+
CDMOs need: high-shear mixing and homogenization equipment, controlled temperature processing (many topicals require specific heating/cooling profiles), multiple filling formats (tubes, jars, pump bottles, airless dispensers), stability testing under dermatological conditions (photostability, temperature cycling), in vitro release testing (IVRT) and in vitro permeation testing (IVPT) using Franz diffusion cells, and rheology testing for viscosity specifications. Experience with both aqueous and non-aqueous vehicles is important.
How do generic topical drug requirements differ from oral generics?
Need help finding the right CDMO?
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.
